Fish Oil Supplements for Fatty Liver: UK Guide

Fish oil supplements for fatty liver disease are increasingly discussed as a potential supportive measure, alongside lifestyle changes such as diet and exercise. Fatty liver disease, now clinically termed metabolic dysfunction-associated steatotic liver disease (MASLD), affects a significant proportion of the UK population. Fish oil is rich in omega-3 fatty acids, principally EPA and DHA, which may help reduce liver fat and inflammation. However, fish oil is not licensed as a treatment for fatty liver in the UK, and NICE guidance does not recommend it as a specific pharmacological intervention. This article reviews the evidence, dosing considerations, and safety information.

Can fish oil supplements help with fatty liver disease?

Fish oil supplements may offer modest benefits for fatty liver disease by reducing liver fat and inflammation, but they are not licensed for this use in the UK and should support, not replace, lifestyle management.

Fish oil supplements may offer modest benefits for people with fatty liver disease, particularly by helping to reduce liver fat and inflammation, though they are not a standalone treatment. Fatty liver disease is now clinically termed metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD). It occurs when excess fat accumulates in liver cells, ranging from simple steatosis (fat accumulation without significant inflammation) to the more advanced metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH), which can progress to fibrosis and cirrhosis. UK guidance from NICE and NHS materials may still use the older NAFLD and NASH terminology.

Fish oil is rich in long-chain omega-3 polyunsaturated fatty acids, principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These fatty acids are thought to influence liver fat metabolism by reducing triglyceride production, modulating insulin sensitivity, and exerting anti-inflammatory effects on liver tissue.^[13] These proposed mechanisms make omega-3 supplementation a plausible adjunct to lifestyle modification, though the evidence base continues to evolve.

Fish oil supplements are not licensed as a treatment for fatty liver disease in the UK, and NICE guidance on NAFLD/MASLD (NG49) does not recommend omega-3 supplements as a specific pharmacological intervention.^[3] The cornerstone of management remains lifestyle change, including a balanced diet, regular physical activity, and weight reduction where appropriate. Fish oil should therefore be considered a potential supportive measure rather than a replacement for evidence-based care.

Anyone with known or suspected liver disease should be aware of symptoms that require prompt medical attention. Seek urgent care if you develop jaundice (yellowing of the skin or eyes), vomiting blood, black or tarry stools, or sudden confusion. See your GP if you have persistently abnormal liver blood tests, unexplained fatigue, or risk factors for advanced liver disease. Your GP can assess your risk of liver fibrosis using validated tools such as the FIB-4 score and refer you to a specialist if needed.^[4]

Anyone considering fish oil supplementation for liver health should discuss this with their GP or a specialist, particularly if they have an existing liver condition, take anticoagulant medicines, or have other relevant health concerns.

What does the evidence say about omega-3s and liver health?

Evidence shows omega-3 supplementation can reduce liver fat and improve liver enzyme levels, but effects on liver inflammation and fibrosis are less consistent, and no UK regulator has approved fish oil for fatty liver disease.

Clinical research suggests that omega-3 fatty acids can reduce liver fat content in people with MASLD (formerly NAFLD), though the evidence for improving more advanced markers such as liver inflammation and fibrosis is less consistent. Multiple randomised controlled trials and systematic reviews have examined EPA and DHA supplementation in adults with fatty liver disease, with a number demonstrating statistically significant reductions in hepatic triglyceride content as measured by imaging techniques such as magnetic resonance spectroscopy.

A meta-analysis published in Alimentary Pharmacology and Therapeutics found that omega-3 supplementation was associated with reductions in liver fat and improvements in liver enzyme levels, specifically alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which are used as surrogate markers of liver injury. However, the same body of evidence highlighted that effects on histological outcomes, meaning actual changes seen in liver tissue on biopsy, were less consistently demonstrated. These findings should be interpreted with caution given the heterogeneity of trial designs, doses, and populations studied.

The European Association for the Study of the Liver (EASL) acknowledges omega-3 fatty acids as potentially beneficial for reducing liver steatosis but does not recommend them as a primary pharmacological intervention for MASLD, citing the need for larger, longer-term trials with hard clinical endpoints.^[5] No UK regulatory body has approved a fish oil product specifically for the treatment of fatty liver disease.

It is also worth noting that the quality and concentration of omega-3 in over-the-counter supplements varies considerably. Prescription-grade omega-3 preparations, such as those used in the management of severe hypertriglyceridaemia, contain standardised doses of EPA and DHA, which differ from typical retail supplements. Patients should be cautious about drawing direct comparisons between trial data and commercially available products.

How much fish oil should you take for fatty liver?

There is no officially recommended dose for fatty liver in the UK; clinical trials used 1 to 4 grams of combined EPA and DHA daily, which is higher than most over-the-counter capsules provide.

There is no officially recommended dose of fish oil specifically for fatty liver disease in the UK, as no regulatory body has licensed fish oil supplements for this indication. Clinical trials investigating omega-3s in MASLD have used a wide range of doses, typically between 1 gram and 4 grams of combined EPA and DHA per day, administered over periods ranging from a few months to over a year.^[5] These doses are considerably higher than the amounts typically found in standard over-the-counter fish oil capsules, which commonly contain around 300 milligrams to 500 milligrams of combined EPA and DHA per capsule, though this varies between products.^[6]

The British Dietetic Association advises that adults consume at least two portions of fish per week, one of which should be oily fish such as salmon, mackerel or sardines, as a dietary source of omega-3 fatty acids.^[7] This dietary approach is generally preferred over supplementation as part of a balanced eating pattern. For individuals who do not eat fish, supplementation may be considered, but the appropriate dose should be discussed with a healthcare professional.

Self-prescribing high doses of fish oil without medical supervision is not advisable. At higher doses, fish oil can have clinically relevant effects on bleeding time, as noted in the prescribing information for licensed omega-3 preparations such as Omacor (omega-3-acid ethyl esters).^[12][13] This is particularly relevant for people taking anticoagulant or antiplatelet medicines such as warfarin or direct oral anticoagulants, where close monitoring may be required. People taking these medicines should always consult their GP before starting any omega-3 supplement. If you are due to have surgery or a procedure, inform your surgeon or anaesthetist that you are taking fish oil supplements, as they may advise you to stop beforehand.

For those exploring weight management or liver health support through an online service, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support, where clinically appropriate options can be discussed.

Are there any side effects or risks to be aware of?

Fish oil is generally well tolerated, but at higher doses it can affect bleeding time and interact with anticoagulants; pregnant women should avoid cod liver oil due to its vitamin A content.

Fish oil supplements are generally well tolerated at standard doses, but they can cause side effects, particularly at higher doses used in some clinical studies. The most commonly reported adverse effects are gastrointestinal in nature and include:

• Fishy aftertaste or burping, which can be reduced by taking capsules with food or choosing enteric-coated formulations

• Nausea or loose stools, particularly when starting supplementation or taking higher doses

• Abdominal discomfort, which usually settles with time or dose reduction

At higher doses, fish oil can affect bleeding time, as reflected in the prescribing information for licensed omega-3 products.^[12][13] This is particularly relevant for people taking anticoagulant or antiplatelet medicines, including aspirin, warfarin, apixaban or rivaroxaban. Anyone on these medicines should seek GP advice before starting fish oil supplements. If you have a known bleeding disorder, or are planning surgery, discuss fish oil use with your clinician beforehand.

Fish oil supplements derived from fish liver, such as cod liver oil, also contain vitamins A and D. High doses of vitamin A can be harmful, particularly during pregnancy. NHS and Food Standards Agency guidance advises that pregnant women should avoid cod liver oil and other vitamin A supplements.^[8][9] Standard fish body oil supplements do not carry the same vitamin A risk.

People with a fish or shellfish allergy should exercise caution and seek medical advice before taking fish-derived omega-3 supplements. Algae-based omega-3 supplements, which provide DHA and sometimes EPA, are an alternative for those who cannot take fish-derived products.^[6]

If you experience any unexpected or severe reactions after starting a fish oil supplement, you should contact your GP. Suspected adverse reactions to any supplement or medicine can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. For urgent concerns, contact NHS 111, or call 999 only in a life-threatening emergency.

Scientific References

1. Understanding the evolving nomenclature of steatotic liver disease.
2. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
3. Metabolic dysfunction-associated steatotic liver disease (NG49).
4. LIVERFASt for assessing and monitoring liver fibrosis, activity and steatosis.
5. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease.
6. Omega-3 food fact sheet.
7. Omega-3 – British Dietetic Association.
8. Pregnancy vitamins and supplements.
9. Vitamin A – Vitamins and minerals.
10. Fish and shellfish.
11. Lay summary of the statement on the effects of excess vitamin A on maternal health.
12. New safety information for omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000 mg capsules).
13. Omega 3-acid-ethyl esters 1000 mg soft capsules – Summary of Product Characteristics.
14. Package Leaflet: Information for the User – Omacor.
15. Clinical overview of Omacor: a concentrated formulation of omega-3 fatty acids.

Frequently Asked Questions